7月29日连板股分析：全市场2连板以上个股仅一只 创新药、CXO概念强者恒强

Group 1 - The core viewpoint of the article highlights the strong performance of innovative drugs and CXO concepts, with only one stock achieving three consecutive limit-ups, while the overall market shows a significant number of declines [1] - A total of 43 stocks hit the daily limit, with 9 stocks showing consecutive limit-ups, and a limit-up advancement rate of 20% excluding ST and delisted stocks [1] - The article notes that apart from Xizang Tourism, which achieved a limit-up, all other consecutive limit-up stocks experienced a breakdown, indicating a severe gap in consecutive limit-up stocks [1] Group 2 - The article provides specific data on stocks with consecutive limit-ups, including Xizang Tourism with a 100% advancement rate, and other stocks like Shanhua Intelligent and Nanfang Road Machinery showing lower advancement rates [2] - It mentions that the super hydropower concept continues to show strong speculative behavior, with stocks like Tuoshan Heavy Industry experiencing significant volatility [1] - The innovative drug sector is highlighted with companies like Yatai Pharmaceutical and Chenxin Pharmaceutical showing strong consecutive limit-up performances, alongside news of WuXi AppTec's better-than-expected half-year results and an upward revision of its annual revenue guidance [1]